NCT01167153 Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients Status COMPLETED Phase PHASE4
NCT01163929 A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer Status WITHDRAWN Phase PHASE2
NCT01160094 Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) Status COMPLETED Phase N/A
NCT01159418 LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT01157858 Everolimus and LongActing Octreotide Trial in Polycystic Livers Status COMPLETED Phase PHASE2
NCT01155817 Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease Status COMPLETED Phase PHASE1
NCT01149993 Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation Status WITHDRAWN Phase PHASE4
NCT01148628 Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT01147003 Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures Status COMPLETED Phase PHASE2
NCT01140568 Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas Status COMPLETED Phase PHASE2
NCT01139138 Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01136395 Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation Status COMPLETED Phase PHASE2
NCT01130662 Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01127750 Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients Status COMPLETED Phase PHASE3
NCT01125293 Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia Status TERMINATED Phase PHASE1/PHASE2
NCT01123941 Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old) Status COMPLETED Phase PHASE1
NCT01122199 Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01120028 Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy Status COMPLETED Phase PHASE2/PHASE3